Your Search Returned 3 tagged news reports
The patent will provide protection for LOR-253 composition of matter along with the coverage of Lorus lead antimicrobial small molecule LOR-220, which is used to treat drug resistant bacterial infections. Lorus president and CEO Aiping Young said the
Tags:
The patent protects the use of IL-17E to treat cancer, including solid tumors such as colon, breast, ovarian, pancreatic and lung cancers in addition to melanoma until 2026. The treatment of cancers with IL-17E in combination with several approved
Tags:
Lorus has discovered IL-17E (also known as IL-25) cytokine that plays a vital role in inflammation and has potent anticancer properties. Lorus president and CEO Aiping Young said the company's scientists have discovered the anticancer properties of
Tags: